Literature DB >> 8643517

Induction of alloantigen-specific tolerance by B cells from CD40-deficient mice.

G A Holländer1, E Castigli, R Kulbacki, M Su, S J Burakoff, J C Gutierrez-Ramos, R S Geha.   

Abstract

Interaction between CD40 on B cells and CD40 ligand molecules on T cells is pivotal for the generation of a thymus-dependent antibody response. Here we show that B cells deficient in CD40 expression are unable to elicit the proliferation of allogeneic T cells in vitro. More importantly, mice immunized with CD40-/- B cells become tolerant to allogeneic major histocompatibility complex (MHC) antigens as measured by a mixed lymphocyte reaction and cytotoxic T-cell assay. The failure of CD40-/- B cells to serve as antigen presenting cells in vitro was corrected by the addition of anti-CD28 mAb. Moreover, lipopolysaccharide stimulation, which upregulates B7 expression, reversed the inability of CD40-/- B cells to stimulate an alloresponse in vitro and abrogated the capacity of these B cells to induce tolerance in vivo. These results suggest that CD40 engagement by CD40 ligand expressed on antigen-activated T cells is critical for the upregulation of B7 molecules on antigen-presenting B cells that subsequently deliver the costimulatory signals necessary for T-cell proliferation and differentiation. Our experiments suggest a novel strategy for the induction of antigen-specific tolerance in vivo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8643517      PMCID: PMC39394          DOI: 10.1073/pnas.93.10.4994

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones.

Authors:  F A Harding; J G McArthur; J A Gross; D H Raulet; J P Allison
Journal:  Nature       Date:  1992-04-16       Impact factor: 49.962

2.  A cell culture model for T lymphocyte clonal anergy.

Authors:  R H Schwartz
Journal:  Science       Date:  1990-06-15       Impact factor: 47.728

Review 3.  T-lymphocyte-antigen interactions in transplant rejection.

Authors:  A M Krensky; A Weiss; G Crabtree; M M Davis; P Parham
Journal:  N Engl J Med       Date:  1990-02-22       Impact factor: 91.245

4.  Differential regulatory signals delivered by antibody binding to the CD28 (Tp44) molecule during the activation of human T lymphocytes.

Authors:  N K Damle; L V Doyle; L S Grosmaire; J A Ledbetter
Journal:  J Immunol       Date:  1988-03-15       Impact factor: 5.422

5.  T helper cell subsets require the expression of distinct costimulatory signals by antigen-presenting cells.

Authors:  C T Weaver; C M Hawrylowicz; E R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

6.  CTLA-4 is a second receptor for the B cell activation antigen B7.

Authors:  P S Linsley; W Brady; M Urnes; L S Grosmaire; N K Damle; J A Ledbetter
Journal:  J Exp Med       Date:  1991-09-01       Impact factor: 14.307

7.  CD40 and IgE: synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells.

Authors:  H H Jabara; S M Fu; R S Geha; D Vercelli
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307

8.  The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity.

Authors:  D Hollenbaugh; L S Grosmaire; C D Kullas; N J Chalupny; S Braesch-Andersen; R J Noelle; I Stamenkovic; J A Ledbetter; A Aruffo
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

9.  Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens.

Authors:  E E Eynon; D C Parker
Journal:  J Exp Med       Date:  1992-01-01       Impact factor: 14.307

10.  The CD28 ligand B7/BB1 provides costimulatory signal for alloactivation of CD4+ T cells.

Authors:  L Koulova; E A Clark; G Shu; B Dupont
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

View more
  12 in total

1.  Deconstructing tick saliva: non-protein molecules with potent immunomodulatory properties.

Authors:  Carlo José F Oliveira; Anderson Sá-Nunes; Ivo M B Francischetti; Vanessa Carregaro; Elen Anatriello; João S Silva; Isabel K F de Miranda Santos; José M C Ribeiro; Beatriz R Ferreira
Journal:  J Biol Chem       Date:  2011-01-26       Impact factor: 5.157

2.  Impaired IgA class switching in APRIL-deficient mice.

Authors:  Emanuela Castigli; Sumi Scott; Fatma Dedeoglu; Paul Bryce; Haifa Jabara; Atul K Bhan; Emiko Mizoguchi; Raif S Geha
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-26       Impact factor: 11.205

Review 3.  B-cell involvement in the pathogenesis of RA-is there a contribution of the sympathetic nervous system?

Authors:  Georg Pongratz; Rainer H Straub
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

Review 4.  The hyper-IgM (HIM) syndrome.

Authors:  N Ramesh; M Seki; L D Notarangelo; R S Geha
Journal:  Springer Semin Immunopathol       Date:  1998

5.  Impaired CD19 expression and signaling, enhanced antibody response to type II T independent antigen and reduction of B-1 cells in CD81-deficient mice.

Authors:  E N Tsitsikov; J C Gutierrez-Ramos; R S Geha
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

Review 6.  Regulation of NF-κB by TNF family cytokines.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Semin Immunol       Date:  2014-06-21       Impact factor: 11.130

7.  Bone marrow-derived cells are required for the induction of a pulmonary inflammatory response mediated by CD40 ligation.

Authors:  J A Wiley; A G Harmsen
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

8.  CD4(+) T cells tolerized ex vivo to host alloantigen by anti-CD40 ligand (CD40L:CD154) antibody lose their graft-versus-host disease lethality capacity but retain nominal antigen responses.

Authors:  B R Blazar; P A Taylor; R J Noelle; D A Vallera
Journal:  J Clin Invest       Date:  1998-08-01       Impact factor: 14.808

Review 9.  X-linked immunodeficiency with hyper-IgM (XHIM).

Authors:  L D Notarangelo; A R Hayward
Journal:  Clin Exp Immunol       Date:  2000-06       Impact factor: 4.330

10.  Allelic exclusion of the T cell receptor beta locus requires the SH2 domain-containing leukocyte protein (SLP)-76 adaptor protein.

Authors:  I Aifantis; V I Pivniouk; F Gärtner; J Feinberg; W Swat; F W Alt; H von Boehmer; R S Geha
Journal:  J Exp Med       Date:  1999-10-18       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.